npc 12626 has been researched along with 2-amino-5-phosphonovalerate in 5 studies
| Studies (npc 12626) | Trials (npc 12626) | Recent Studies (post-2010) (npc 12626) | Studies (2-amino-5-phosphonovalerate) | Trials (2-amino-5-phosphonovalerate) | Recent Studies (post-2010) (2-amino-5-phosphonovalerate) |
|---|---|---|---|---|---|
| 55 | 0 | 0 | 4,393 | 1 | 539 |
| Protein | Taxonomy | npc 12626 (IC50) | 2-amino-5-phosphonovalerate (IC50) |
|---|---|---|---|
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 0.29 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.29 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.29 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 0.29 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 0.29 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 0.29 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 0.29 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conti, L; Ellenberger, SR; Ellenberger, WP; Ferkany, JW; Guzewska, ME; Hudkins, R; Kyle, DJ; Narayanan, BA; Patch, R; Rzeszotarski, WJ | 1 |
| Balster, RL; Gold, LH | 1 |
| Brandsgaard, RR; Clissold, DB; Ferkany, JW; Hamilton, GS; Hartman, TL; Willetts, J | 1 |
| Cain, DP; Saucier, D | 1 |
| Edwards, MA; Kantak, KM; O'Connor, TP | 1 |
5 other study(ies) available for npc 12626 and 2-amino-5-phosphonovalerate
| Article | Year |
|---|---|
Pharmacological profile of novel cyclic analogs of 2-amino-7-phosphonoheptanoic acid.
Topics: 2-Amino-5-phosphonovalerate; Amino Acids; Animals; Anticonvulsants; Brain; Dose-Response Relationship, Drug; Electroshock; Male; Mice; N-Methylaspartate; Pentylenetetrazole; Receptors, N-Methyl-D-Aspartate; Seizures; Structure-Activity Relationship | 1992 |
Effects of NMDA receptor antagonists in squirrel monkeys trained to discriminate the competitive NMDA receptor antagonist NPC 12626 from saline.
Topics: 2-Amino-5-phosphonovalerate; Amino Acids; Animals; Discrimination Learning; Dizocilpine Maleate; Male; Piperazines; Receptors, N-Methyl-D-Aspartate; Saimiri | 1993 |
Behavioral pharmacology of NPC 17742, a competitive N-methyl-D-aspartate (NMDA) antagonist.
Topics: 2-Amino-5-phosphonovalerate; Amino Acids; Animals; Behavior, Animal; Binding, Competitive; Dose-Response Relationship, Drug; Isoquinolines; Male; Mice; Pipecolic Acids; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 1993 |
Competitive NMDA receptor antagonists do not block cholinergic kindling with carbachol.
Topics: 2-Amino-5-phosphonovalerate; Amino Acids; Animals; Binding, Competitive; Carbachol; Cholinergic Agonists; Electric Stimulation; Electrodes, Implanted; Excitatory Amino Acid Antagonists; Kindling, Neurologic; Male; Rats; Receptors, N-Methyl-D-Aspartate | 1996 |
Modulation of the discriminative stimulus and rate-altering effects of cocaine by competitive and noncompetitive N-methyl-D-aspartate antagonists.
Topics: 2-Amino-5-phosphonovalerate; Amino Acids; Animals; Binding, Competitive; Cocaine; Discrimination Learning; Dizocilpine Maleate; Dopamine Uptake Inhibitors; Drug Interactions; Excitatory Amino Acid Antagonists; Magnesium Chloride; Male; Phencyclidine; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Reinforcement Schedule | 1998 |